IL7 (Interleukin-7) and IL21 (Interleukin-21) modified NK92 (Natural Killer-92) cell as well as preparation method and application thereof

A technology of NK cells and cell membranes, which is applied in the field of biomedicine and can solve the problems of poor cell state and irreversibility.

Active Publication Date: 2018-05-22
PERSONGEN BIOMEDICINESUZHOUCO
View PDF11 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The cell state will become worse and worse after the

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • IL7 (Interleukin-7) and IL21 (Interleukin-21) modified NK92 (Natural Killer-92) cell as well as preparation method and application thereof
  • IL7 (Interleukin-7) and IL21 (Interleukin-21) modified NK92 (Natural Killer-92) cell as well as preparation method and application thereof
  • IL7 (Interleukin-7) and IL21 (Interleukin-21) modified NK92 (Natural Killer-92) cell as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0228] Example 1 Construction of NK92MI / IL21 and NK92MI / IL7&21 cell lines

[0229] Molecular structure design of the first fusion protein: GM-CSF signal peptide-IL7 sequence-hinge region-Fc segment-CD4 transmembrane region

[0230] Molecular structure design of the second fusion protein: GM-CSF signal peptide-IL21 sequence-hinge region-Fc segment-CD4 transmembrane region

[0231]The first fusion protein coding sequence and the second fusion protein coding sequence are synthesized by gene synthesis, and the present invention synthesizes the first fusion protein coding sequence (SEQ ID NO.:9) and the second fusion protein coding sequence (SEQ ID NO. : 10) were respectively constructed on the pHULK piggyBac N-Comet GFP vector (BioVector NTCC Plasmid Vector Strain Cell Gene Collection Center), and the IL7-pHULK piggyBac N-Comet GFP plasmid and the IL21-pHULK piggyBac N-Comet GFP plasmid were successfully constructed. First, the IL21-pHULK piggyBac N-Comet GFP plasmid was electrop...

Embodiment 2

[0233] Example 2 Comparison of cytotoxicity and in vitro proliferation of NK92MI, NK92MI / IL21 and NK92MI / IL7&21 cells

[0234] In the in vitro killing test, CFSE / 7-AAD flow detection method was used for the detection of killing results. Specifically, the target cells were taken in a 15ml centrifuge tube, resuspended in PBS, added a small amount of CFSE and incubated at 37°C for 30 minutes, and the target cells were taken. Cell 4×10 5 each in a 24-well plate, then add the corresponding number of effector cells, mix well, and the final system is 1.5ml. Effector cells and target cells were co-cultured, then the supernatant was removed, washed once with PBS, and after resuspended in PBS, 2ul 7-AAD was added to each group, and then detected on the FACS Calibur machine. The CFSE positive cell population is the target cell, and the proportion of the 7-AAD positive cell population in this cell population is the death rate of the target cell.

[0235] NK92MI, NK92MI / IL21 and NK92MI / I...

Embodiment 3

[0245] Example 3 Phenotype analysis of PBMC cells co-cultured with NK92MI, NK92MI / IL7, NK92MI / IL21 and NK92MI / IL7&21 cells

[0246] In order to understand whether NK92MI, NK92MI / IL7, NK92MI / IL21 and NK92MI / IL7&21 cells have influence on the activation of T cells in normal people after entering the human body, the present invention has carried out a simulation test in vitro. The present invention extracts the peripheral blood of three normal people, extracts PBMC cells respectively, and divides the obtained PBMC cell counts into 5 groups (placed in 24-well plates for culture, and the medium used is RPMI1640). The first group puts 1×10 6 PBMC cells, without any treatment, as a negative control for flow cytometry analysis; put 1×10 in the second group 6 PBMC cells, add IL2 and 2012 cells to activate and expand T cells, as a positive control for flow analysis; put 1×10 in the third group 6 PBMC cells, then add 1×10 5 NK92MI cells were co-cultured; the fourth group put 1×10 6 P...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides an IL7 (Interleukin-7) and IL21 (Interleukin-21) modified NK92 (Natural Killer-92) cell as well as a preparation method and application thereof. Particularly, the NK cell provided by the invention can be used for effectively killing a tumor cell, is obviously enhanced in in-vitro multiplication capacity, is easily proliferated in vitro, can be cultured in a high-density manner, has quite high killing capacity, a low production code and a few side effects, and does not have a risk of a graft versus host disease. Moreover, the NK cell can be used for obviously stimulatingthe activation and the amplification of a T (thymus) cell to cooperate with each other for jointly killing the tumor cell; the immune response of an organism is effectively enhanced; meanwhile, no cytotoxicity exists between the NK cell and the T cell each other, and a respective killing effect on a target cell is also not influenced.

Description

technical field [0001] The invention belongs to the field of biomedicine, in particular, the invention relates to NK92 cells modified with IL7 and IL21, a preparation method and application thereof. Background technique [0002] Cellular immunotherapy is an emerging tumor treatment mode with significant curative effect, and it is a new type of autoimmune anti-cancer treatment. It is a method of using biotechnology and biological agents to culture and expand immune cells collected from patients in vitro and then infuse them back into the patient's body to stimulate and enhance the body's autoimmune function, so as to achieve the purpose of treating tumors. [0003] In recent years, NK cells have shown great application prospects in adoptive cellular immunotherapy. Relevant clinical trials have shown that injections for patients with advanced cancer have less side effects. The NK-92 cell line, derived from peripheral blood mononuclear cells of a patient with non-Hodgkin's ly...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/10C12N15/85C12N15/62A61K35/17A61P35/00
CPCA61K35/17C07K14/54C07K14/5418C07K2319/00C07K2319/02C07K2319/03C12N5/0646C12N15/85
Inventor 杨林张平
Owner PERSONGEN BIOMEDICINESUZHOUCO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap